Status:
COMPLETED
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
Lead Sponsor:
University Hospital, Ioannina
Collaborating Sponsors:
INTERNAL MEDICINE DEPARTMENT, 1ST WARD
Conditions:
SARS-COV2 Infection
COVID-19 Disease
Eligibility:
All Genders
18+ years
Brief Summary
Effect of Covid-19 disease in clotting factors levels in hospitalized patients
Detailed Description
Effect of Covid-19 disease in clotting factors levels in hospitalized patients positive for sars-cov2 infection. Association between clotting factors levels and disease severity,morbidity and mortali...
Eligibility Criteria
Inclusion
- AGE\> 18
- SINGED INFORMED CONSENT FORM
- POSITIVE PCR TEST FOR SARS-COV2 INFECTION
- FINDINGS IN CXR OR CT OF THE LUNGS CONSISTENT WITH INFECTION OF LOWER RESPIRATORY TRACT
Exclusion
- AGE\<18
- DENIAL TO PROVIDE INFORMED CONSENT FORM
- HISTORY OF MALIGNANCY
- PRIOR USE OF ANTICOAGULANT THERAPY
- PRIOR USE OF STEROIDS LONGER THAN 14 DAYS
- LACTATION-PREGNANCY
Key Trial Info
Start Date :
December 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 23 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04787510
Start Date
December 23 2020
End Date
June 23 2021
Last Update
September 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University General Hospital of Ioannina
Ioannina, Epirus, Greece, 45500